Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1998
10/13/1998US5821239 Substituted-4-amino-3-pyridinols
10/13/1998US5821231 Treatment of immunoinflammatory conditions
10/13/1998US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998US5821219 Opioid antagonists and methods of their use
10/13/1998US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998US5821123 Modified antibody variable domains
10/13/1998US5821086 Polynucleotide fragment encoding polypeptide
10/08/1998WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998WO1998044103A2 Protein for inhibiting apoptosis
10/08/1998WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998WO1998043660A1 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
10/08/1998WO1998043648A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/08/1998WO1998043646A1 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
10/08/1998WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998WO1998043621A1 Nitrosylation to inactivate apoptotic enzymes
10/08/1998WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
10/08/1998WO1998022104A3 Treatment of neurodegenerative conditions with nimesulide
10/08/1998CA2285434A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/08/1998CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998CA2283799A1 Novel human serine carboxypeptidase
10/08/1998CA2234025A1 Novel compounds with pharmaceutical properties
10/07/1998EP0869180A1 A TNF homologue, TL5
10/07/1998EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0869131A1 5-halo-5-deoxy sorbopyranose compounds
10/07/1998EP0869122A1 Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
10/07/1998EP0869119A1 Phenoxymethyl piperidine derivatives being sodium channle blockers
10/07/1998EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868185A1 Method for treating depression
10/07/1998EP0868181A1 USE OF $g(a),$g(a)-DIPHENYLACETIC ACID-4-(N-METHYL-PIPERIDYL)ESTER AS ANTI-SPASMODIC
10/07/1998EP0868180A1 Endothelin receptor antagonists
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/07/1998EP0712311B1 Antiglucocorticoid steroids for the treatment of anxiety disorders
10/07/1998EP0711271B1 Aminoindanes and related compounds useful as calcium-channel antagonists
10/07/1998EP0708771B1 Benzyloxyquinuclidines as substance p antagonists
10/07/1998EP0662948B1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
10/07/1998EP0558487B1 Piperidine compounds, their preparation and use
10/07/1998CN1195344A Polycyclic alcaloid-derivatives as NMDA-receptor antagonists
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998CN1195287A Treatment of attention-deficit and hyperactivity disorder
10/07/1998CN1194983A New 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them
10/07/1998CN1194977A Phenoxymethyl piperidine derivatives
10/07/1998CN1194976A Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament, and medicament comprising them
10/07/1998CN1040106C Process for preparing piperazine derivatives
10/07/1998CN1040105C Process for preparing aminoketone derivatives
10/07/1998CN1040062C Process for preparing pharmacologically active catechol derivatives
10/06/1998US5817833 Antiserotonin agents; nervous system disorders; psychological disorders; antidepressants
10/06/1998US5817815 Pharmacologically active enantiomers
10/06/1998US5817698 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/06/1998US5817684 Administering an aromatic alcohol compound
10/06/1998US5817679 Analgesics, antiinflammatory agents
10/06/1998US5817676 Indazolecarboxamides
10/06/1998US5817674 Antiotensin ii receptor antagonists
10/06/1998US5817671 Antiserotonin agent; analgesics; migraine therapy; compound containing pyrrolo(3,2-b)pyridine ring
10/06/1998US5817668 S-heteroatom containing alkyl substituted-3-oxo-pyrido 1,2-A!benzimidozole-4-carboxamide derivatives useful in treating central nervous system disorders
10/06/1998US5817651 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles
10/06/1998US5817631 Therapeutic uses of melanin
10/06/1998US5817629 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
10/06/1998US5817622 Cloning dna sequences
10/06/1998US5817496 Kynurenine aminotransferase
10/06/1998US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998US5817480 DNA encoding a histamine H2 receptor
10/06/1998US5816260 Method for treating substance abuse withdrawal
10/06/1998CA2168131C Tetrahydro-1h-benzazepinones containing acid surrogates
10/06/1998CA2012313C Thienylacetic acid derivatives, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof
10/06/1998CA1340074C Benzodiazepines, process and intermediates for the preparation thereof and their applications in therapy
10/03/1998CA2232147A1 Phenoxymethyl piperidine derivatives
10/02/1998CA2233787A1 Sialoadhesin family member-3
10/02/1998CA2233785A1 Tumor necrosis related receptor, tr7
10/02/1998CA2232743A1 A tnf homologue, tl5
10/02/1998CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/02/1998CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998WO1998043094A1 METHODS TO IDENTIFY β-AMYLOID REDUCING AGENTS
10/01/1998WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998WO1998042738A1 87 human secreted proteins
10/01/1998WO1998042713A1 2,3-DIHYDROFURO[3,2-b]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY
10/01/1998WO1998042706A1 Method of making arylamino triazolopyridines
10/01/1998WO1998042699A1 4-tetrahydropyridylpyrimidine derivatives
10/01/1998WO1998042696A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
10/01/1998WO1998042675A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998WO1998042674A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998WO1998042673A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
10/01/1998WO1998042382A1 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
10/01/1998WO1998042344A1 Pharmaceutical composition
10/01/1998WO1998042275A1 Method of treatment of migraine
10/01/1998WO1998042209A1 Decaffeinated mate extracts and the use thereof
10/01/1998WO1998027206A3 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/01/1998WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998CA2284719A1 Nasal melatonin composition
10/01/1998CA2284710A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
10/01/1998CA2284550A1 87 human secreted proteins
10/01/1998CA2284261A1 Methods to identify .beta.-amyloid reducing agents
10/01/1998CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998CA2283230A1 Method of making arylamino triazolopyridines
10/01/1998CA2282320A1 2,3-dihydrofuro¬3,2-b|pyridin, preparation and application thereof in therapy
10/01/1998CA2282275A1 Method of treatment of migraine
10/01/1998CA2232461A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/1998
09/30/1998EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
1 ... 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 ... 1833